Merck & Co., Inc.
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Eisai Co., Ltd. (Lenvima Oncology Alliance) by Year
Eisai Co., Ltd. (Lenvima Oncology Alliance) — Cost of sales profit-sharing & manufacturing ($M) ($M)
Merck Eisai Co., Ltd. (Lenvima Oncology Alliance): $241M in FY2025, unchanged from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-24) ↗
Reported in Form 10-Q / 10-K Note 3/4 Collaborative Arrangements.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Eisai Co., Ltd. (Lenvima Oncology Alliance) — Cost of sales profit-sharing & manufacturing ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 241 | 0.0% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 241 | -36.7% | Form 10-K (filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 381 | +79.7% | Form 10-K (filed 2026-02-24) ↗ |
| FY2022 | Dec 31, 2022 | 212 | +8.7% | Form 10-K (filed 2025-02-25) ↗ |
| FY2021 | Dec 31, 2021 | 195 | -28.0% | Form 10-K (filed 2024-02-26) ↗ |
| FY2020 | Dec 31, 2020 | 271 | +31.6% | Form 10-K (filed 2023-02-24) ↗ |
| FY2019 | Dec 31, 2019 | 206 | – | Form 10-K (filed 2022-02-25) ↗ |
Cite this data
StockData. (2026). Merck Eisai Co., Ltd. (Lenvima Oncology Alliance) ($M), annual FY2019–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/collab-eisai-cos
See every metric in the Merck KPI table. Data updated Oct 26, 2026.